Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Treatment of bullous pemphigoid with low-dose oral cyclophosphamide: a case series of 20 patients.

Gual A, Iranzo P, Mascaró JM Jr.

J Eur Acad Dermatol Venereol. 2014 Jun;28(6):814-8. doi: 10.1111/jdv.12155.

PMID:
23581830
2.
3.

Low-dose methotrexate treatment in elderly patients with bullous pemphigoid.

Paul MA, Jorizzo JL, Fleischer AB Jr, White WL.

J Am Acad Dermatol. 1994 Oct;31(4):620-5.

PMID:
8089289
4.

Efficacy and safety of cyclophosphamide, azathioprine, and cyclosporine (ciclosporin) as adjuvant drugs in pemphigus vulgaris.

Olszewska M, Kolacinska-Strasz Z, Sulej J, Labecka H, Cwikla J, Natorska U, Blaszczyk M.

Am J Clin Dermatol. 2007;8(2):85-92.

PMID:
17428113
5.

Rituximab for treatment-refractory pemphigus and pemphigoid: a case series of 17 patients.

Kasperkiewicz M, Shimanovich I, Ludwig RJ, Rose C, Zillikens D, Schmidt E.

J Am Acad Dermatol. 2011 Sep;65(3):552-8. doi: 10.1016/j.jaad.2010.07.032.

PMID:
21641080
6.

Immunosuppressive therapy for autoimmune bullous diseases.

Meurer M.

Clin Dermatol. 2012 Jan-Feb;30(1):78-83. doi: 10.1016/j.clindermatol.2011.03.013. Review.

PMID:
22137230
7.

Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.

Gürcan HM, Ahmed AR.

Am J Clin Dermatol. 2009;10(6):383-96. doi: 10.2165/11310740-000000000-00000. Review.

PMID:
19824739
8.

[Dexamethasone-cyclophosphamide pulse therapy in bullous autoimmune dermatoses].

Appelhans M, Bonsmann G, Orge C, Bröcker EB.

Hautarzt. 1993 Mar;44(3):143-7. German.

PMID:
8463094
9.

Low-dose oral pulse methotrexate as monotherapy in elderly patients with bullous pemphigoid.

Heilborn JD, Ståhle-Bäckdahl M, Albertioni F, Vassilaki I, Peterson C, Stephansson E.

J Am Acad Dermatol. 1999 May;40(5 Pt 1):741-9.

PMID:
10321603
10.

Oral lesions in patients with pemphigus vulgaris and bullous pemphigoid.

Budimir J, Mihić LL, Situm M, Bulat V, Persić S, Tomljanović-Veselski M.

Acta Clin Croat. 2008 Mar;47(1):13-8.

PMID:
18714642
11.

Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid.

Tirado-Sánchez A, Díaz-Molina V, Ponce-Olivera RM.

Allergol Immunopathol (Madr). 2012 May-Jun;40(3):152-5. doi: 10.1016/j.aller.2010.12.009.

PMID:
21497011
12.

[One year follow-up of patients with bullous pemphigoid].

Doffoel-Hantz V, Sparsa A, Marin B, Durox H, Bonnetblanc JM, Bédane C.

Ann Dermatol Venereol. 2009 May;136(5):407-11. doi: 10.1016/j.annder.2009.01.009. French.

PMID:
19442795
13.
14.

A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.

Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D'Incan M, Plantin P, Bedane C, Young P, Bernard P; Bullous Diseases French Study Group..

N Engl J Med. 2002 Jan 31;346(5):321-7.

15.
17.

[Efficacy of rituximab in a case of refractory bullous pemphigoid].

Reguiaï Z, Tchen T, Perceau G, Bernard P.

Ann Dermatol Venereol. 2009 May;136(5):431-4. doi: 10.1016/j.annder.2008.10.038. French.

PMID:
19442800
18.

High-dose methylprednisolone in the treatment of bullous pemphigoid.

Siegel J, Eaglstein WH.

Arch Dermatol. 1984 Sep;120(9):1157-65.

PMID:
6383221
19.

Analysis of high-dose intravenous immunoglobulin therapy in 16 patients with refractory autoimmune blistering skin disease: high efficacy and no serious adverse events.

Seidling V, Hoffmann JH, Enk AH, Hadaschik EN.

Acta Derm Venereol. 2013 May;93(3):346-9. doi: 10.2340/00015555-1471.

20.

A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.

Kjellman P, Eriksson H, Berg P.

Arch Dermatol. 2008 May;144(5):612-6. doi: 10.1001/archderm.144.5.612.

PMID:
18490587
Items per page

Supplemental Content

Support Center